Effect of Topical Recombinant Human Epidermal Growth Factor on Short-Term Wound Area Reduction in Chronic Diabetic Foot Ulcers: A Randomized Controlled Trial

Chronic diabetic ulcers are a main complication of diabetes mellitus and frequently require effective treatment to advance wound healing and prevent complications. This study evaluated topical Recombinant Human Epidermal Growth Factor (rhEGF) compared with conventional saline dressing for managing chronic diabetic ulcers. We conducted a randomized controlled trial at a tertiary care teaching hospital from September 2022 to May 2024. A total of 100 patients with diabetic foot ulcers were randomly assigned to receive each topical rhEGF ointment (Group A, n = 50) or conventional saline dressing (Group B, n = 50). Wound size was assessed at baseline, Day 7, and Day 14 using the graph paper method. The primary result was a reduction in wound size. Baseline demographic and clinical variables were comparable among the groups. By Day 14, Group A demonstrated a significantly smaller mean wound size than Group B (5.78 ± 2.64 cm 2 vs 8.33 ± 3.71 cm 2 ; P = .0001). Topical rhEGF was associated with greater short-term reduction in wound surface area compared with conventional saline dressing over 14 days. These findings indicate a potential short-term benefit in wound-area reduction during inpatient treatment; however, complete wound healing, time to healing, recurrence, amputation, graft take, adverse events, and post-discharge outcomes were not assessed. These findings therefore should not be interpreted as evidence of improved overall healing or long-term clinical effectiveness.

Authors

Institutions

Publication Details

Journal
The International Journal of Lower Extremity Wounds
Published
2026-11-19
DOI
https://doi.org/10.1177/15347346261500156
Primary Topic
Diabetic Foot Ulcer Assessment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Effect of Topical Recombinant Human Epidermal Growth Factor on Short-Term Wound Area Reduction in Chronic Diabetic Foot Ulcers: A Randomized Controlled Trial

Babu Subramanian, Deepak Ravi, Manoharan Gudipati Venkataraman, Sneha Daffodil Arul John Bosco
The International Journal of Lower Extremity Wounds
Diabetic Foot Ulcer Assessment and Management
article

Effect of Topical Recombinant Human Epidermal Growth Factor on Short-Term Wound Area Reduction in Chronic Diabetic Foot Ulcers: A Randomized Controlled Trial

Babu Subramanian, Deepak Ravi, Manoharan Gudipati Venkataraman, Sneha Daffodil Arul John Bosco
article en

Abstract

Chronic diabetic ulcers are a main complication of diabetes mellitus and frequently require effective treatment to advance wound healing and prevent complications. This study evaluated topical Recombinant Human Epidermal Growth Factor (rhEGF) compared with conventional saline dressing for managing chronic diabetic ulcers. We conducted a randomized controlled trial at a tertiary care teaching hospital from September 2022 to May 2024. A total of 100 patients with diabetic foot ulcers were randomly assigned to receive each topical rhEGF ointment (Group A, n = 50) or conventional saline dressing (Group B, n = 50). Wound size was assessed at baseline, Day 7, and Day 14 using the graph paper method. The primary result was a reduction in wound size. Baseline demographic and clinical variables were comparable among the groups. By Day 14, Group A demonstrated a significantly smaller mean wound size than Group B (5.78 ± 2.64 cm 2 vs 8.33 ± 3.71 cm 2 ; P = .0001). Topical rhEGF was associated with greater short-term reduction in wound surface area compared with conventional saline dressing over 14 days. These findings indicate a potential short-term benefit in wound-area reduction during inpatient treatment; however, complete wound healing, time to healing, recurrence, amputation, graft take, adverse events, and post-discharge outcomes were not assessed. These findings therefore should not be interpreted as evidence of improved overall healing or long-term clinical effectiveness.

The International Journal of Lower Extremity Wounds
Sri Manakula Vinayagar Medical College and Hospital (IN)
Diabetic Foot Ulcer Assessment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon